Navigation Links
Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
Date:3/31/2008

tates, it does have limitations. One such limitation is poor sensitivity of individual Pap smears, which means the test misses cancers or precancerous changes. As a result, regular and repeated Pap testing is required to effectively detect a high proportion of cervical cancers. Another limitation is that approximately 2 million of the 50 million Pap tests performed annually in the United States have equivocal results, which are known as ASC-US. These women are often subjected to additional invasive tests, including biopsies, most of which prove negative.

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about Gen-Probe's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as believe, will, expect, anticipate, estimate, intend, plan and would. For example, statements concerning new products, potential regulatory approvals, and customer adoption are all forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to diffe
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
2. Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
3. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
4. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
5. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
6. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
7. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
8. Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study
9. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
10. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
11. Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- EuroPharma, Inc. signs exclusive multi-year contract ... super absorbency BCM-95® curcumin and specialized BosPure® ... exclusive distribution territory for these clinically-studied ingredients ... and professional channel, which includes allopathic doctors, ... is a highly absorbable curcumin. Human ...
(Date:12/16/2009)... 16 Verathon®, maker of BladderScan® ... that portable bladder volume ultrasound is now ... for the Prevention of Catheter-Associated Urinary Tract ... introduced in early November 2009, replace the ... The guidelines are located on the ...
(Date:12/16/2009)... Biovista Inc.,today announced that it was awarded the ... 2009 New England Venture Summit, held on December ... edge private companies,driving the future of innovation, was ... privately held companies that play a leading role ... sectors. , "We are ...
Breaking Medicine Technology:EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 2New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 3New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 4New 2009 CDC Guidelines for the Prevention of Catheter-Associated Urinary Tract Infections Include Bladder Volume Ultrasound 5Biovista Inc. Named Top Innovator in Life Sciences 2TOPICA Elects G Kirk Raab as Chairman of the Board 51901 1TOPICA Elects G Kirk Raab as Chairman of the Board 51901 2Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St Louis Mo 51896 1Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St Louis Mo 51896 2Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St Louis Mo 51896 3NeoStem Inc Appoints Leading Chinese Medical Official to Its Advisory Board 13062 1NeoStem Inc Appoints Leading Chinese Medical Official to Its Advisory Board 13062 2NeoStem Inc Appoints Leading Chinese Medical Official to Its Advisory Board 13062 3
... Doctors often mistake the,symptoms of thyroid disease for ... even dementia, says a new edition of a ... diseases are so,wide-ranging, particularly in older men and ... cause and instead focus on common,illnesses that occur ...
... TAIPEI, Taiwan, Aug. 10 /Xinhua-PRNewswire/ -- TaiGen Biotechnology,Inc. ... the,global double-blind Phase II clinical trial of Nemonoxacin ... A total of 265,patients have been admitted to ... expected in the last quarter of 2007. In ...
Other Medicine Technology:You May Have a Thyroid Problem and Not Know It - Particularly If You're Over 60, Says a New Harvard Medical School Report 2TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP) 2
(Date:12/17/2009)... provide Baptist with on-going Healthcare Cost/Risk Analysis reports, activity measures ... improvements as it translates toward reduced claim costs and positive ... , ... Jacksonville, FL (PRWEB) ... risk management company specializing in clinical/claims based cost risk analysis ...
(Date:12/16/2009)... BERKELEY, Calif., Dec. 17 If proposed ... new standards in the employer-based insurance system. Approximately ... the age of 65 rely upon employer-based insurance ... House and Senate versions of reform legislation entail ... vast majority of employees work for firms that ...
(Date:12/16/2009)... Benefit of Children with Autism and Other Special Needs, ... Zachary Levi Join Ben Stiller to Ring in the ... -- At its 13th annual Teddy Bear Ball, The ... & CEO Brian Goldner received the ... far-reaching philanthropic leadership and commitment to children,s causes; ...
(Date:12/16/2009)... -- Immucor, Inc. (Nasdaq: BLUD ), a global ... transfusion industry, today announced that Paul D. Mintz, M.D. ... independent director, effective January 1, 2010. ,, Dr. ... medicine for more than 30 years. He is a ... of Virginia School of Medicine. He also serves as ...
(Date:12/16/2009)... ANN ARBOR, Mich., Dec. 16 The most widely ... a finding that raises social justice questions that must ... benefit from stem cell advances, according to a University ... study of its kind, the U-M team analyzed 47 ... commonly used by stem cell researchers. The scientists determined ...
Breaking Medicine News(10 mins):Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5
... AIMM) today reported a net loss of $8,000, or break ... September 30, 2007, compared,with a net loss of $36,000, or ... ended September 30, 2006. For the nine months ended,September 30, ... share basic,and diluted, compared with net loss of $517,000, or ...
... Aid Rod,Holder has a suspender-like harness that allows ... The Eliminator Racing Chair is recommended for,athletes with ... in and out,of the chair. (Photo: ... the elements or crave competition, Good Shepherd,Rehabilitation Network,s ...
... tissue, VALLEJO, Calif., Nov. 8 Sutter ... the most advanced and accurate,radiation therapy system available. ... North Bay region customized cancer treatment,resulting in quicker, ... breast, prostate, head, neck and lung cancers. ...
... ROANOKE, Va., Nov. 8 This should be a ... to the next can wear on the body,and dampen the ... can provide you with the comfort, support, and,protection your body ... each other and that requires,some travel for them to be ...
... Nov. 8 Top executives of sports ... Bulletin,Board: NNTN) http://www.naturalnutritioninc.com will be ... Vegas, the world,s largest event for healthy ... 6-8, 2007.,Interactive Nutrition,s professionals constantly travel to,ingredient/packaging ...
... products, SEATTLE, Nov. 8 Cell Therapeutics, Inc. ... has been appointed,the company,s Vice President, Commercial Operations. Fong ... marketing experience. Most recently, Fong,was National Sales Director at ... the launch of Ranexa(R) for chronic angina. CTI,recently agreed ...
Other Medicine News:Health News:AutoImmune Inc. Reports 2007 Third Quarter Financial Results 2Health News:AutoImmune Inc. Reports 2007 Third Quarter Financial Results 3Health News:Holiday Gift Giving for Outdoor Enthusiasts With Disabilities and Special Needs 2Health News:Sutter Solano Cancer Center Offers Oncology Patients Customized Cancer Treatment 2Health News:Holiday Travel Causing Stress? 2Health News:Natural Nutrition's Top Executives Attend Supply Side Show West in Las Vegas 2Health News:Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations 2Health News:Cell Therapeutics, Inc. (CTI) Appoints Jim Fong as Vice President, Commercial Operations 3
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: